Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to Stakeholders
Psychedelic-Specific Foundations

Steven & Alexandra Cohen Foundation

United States
7 Trials

One of the largest private philanthropic funders of psychedelic research, having committed over $60 million to the field. The Foundation's Psychedelic Research & Health Initiative supports MDMA-assisted therapy trials for veteran PTSD through MAPS, psilocybin research at Mount Sinai, and patient-assistance programs to ensure equitable access if therapies receive FDA approval.

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit

Collaborated Trials

7
CompletedI

A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

Start Date
November 19, 2024
Compounds
Psilocybin
Active not recruitingI

A Study of Psilocybin for PTSD (PSI-3PO)

Start Date
May 1, 2024
Compounds
Psilocybin
CompletedI, II

Group MDMA-therapy for Veterans With PTSD (Group-MVP)

Start Date
October 1, 2023
Compounds
MDMA
CompletedI, II

Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

Start Date
September 1, 2023
Compounds
Psilocybin
Active not recruitingI

Effects of Repeated Psilocybin Dosing in OCD

Start Date
November 1, 2022
Compounds
Psilocybin
CompletedI

Effects of Psilocybin in Post-Treatment Lyme Disease

Start Date
April 18, 2022
Compounds
Psilocybin
RecruitingI, II

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Start Date
January 15, 2022
Compounds
Psilocybin

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.